{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:30:04Z","timestamp":1790908204360,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.jaci.2011.05.024","type":"journal-article","created":{"date-parts":[[2011,6,29]],"date-time":"2011-06-29T19:54:49Z","timestamp":1309377289000},"page":"847-853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Granulomatous inflammation in cartilage-hair hypoplasia: Risks and benefits of anti\u2013TNF-\u03b1 mAbs"],"prefix":"10.1016","volume":"128","author":[{"given":"Despina","family":"Moshous","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Meyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Fraitag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E.I.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Debr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaan","family":"Toelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"De Boeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Roskams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Deschildre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Capucine","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bodemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2011.05.024_bib1","first-page":"285","article-title":"Dwarfism in the Amish. Ii. Cartilage-hair hypoplasia","volume":"116","author":"McKusick","year":"1965","journal-title":"Bull Johns Hopkins Hosp"},{"key":"10.1016\/j.jaci.2011.05.024_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/jmg.32.1.39","article-title":"Cartilage-hair hypoplasia","volume":"32","author":"Makitie","year":"1995","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaci.2011.05.024_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0022-3476(99)70456-7","article-title":"Increased incidence of cancer in patients with cartilage-hair hypoplasia","volume":"134","author":"Makitie","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2011.05.024_bib4","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/ajmg.a.32478","article-title":"Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma","volume":"146A","author":"Taskinen","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jaci.2011.05.024_bib5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/497708","article-title":"Severely incapacitating mutations in patients with extreme short stature identify RNA-processing endoribonuclease RMRP as an essential cell growth regulator","volume":"77","author":"Thiel","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaci.2011.05.024_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1086\/521034","article-title":"Type and level of RMRP functional impairment predicts phenotype in the cartilage hair hypoplasia-anauxetic dysplasia spectrum","volume":"81","author":"Thiel","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaci.2011.05.024_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clim.2008.11.001","article-title":"Immunologic and clinical features of 25 Amish patients with RMRP 70 A\u2192G cartilage hair hypoplasia","volume":"131","author":"Rider","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2011.05.024_bib8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/ACI.0b013e328310fe7d","article-title":"Cartilage-hair hypoplasia: molecular basis and heterogeneity of the immunological phenotype","volume":"8","author":"Notarangelo","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.05.024_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF01956147","article-title":"Cartilage-hair hypoplasia\u2014clinical manifestations in 108 Finnish patients","volume":"152","author":"Makitie","year":"1993","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaci.2011.05.024_bib10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/adc.84.1.65","article-title":"Increased mortality in cartilage-hair hypoplasia","volume":"84","author":"Makitie","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jaci.2011.05.024_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF02002714","article-title":"Bone marrow transplantation in cartilage-hair hypoplasia: correction of the immunodeficiency but not of the chondrodysplasia","volume":"155","author":"Berthet","year":"1996","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaci.2011.05.024_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jcv.2003.10.007","article-title":"Chronic excretion of a norovirus in a child with cartilage hair hypoplasia (CHH)","volume":"30","author":"Gallimore","year":"2004","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jaci.2011.05.024_bib13","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bmt.1705520","article-title":"Bone marrow transplantation for cartilage-hair-hypoplasia","volume":"38","author":"Guggenheim","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jaci.2011.05.024_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood-2010-01-259168","article-title":"Clinical and immunological outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation","volume":"116","author":"Bordon","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.05.024_bib15","doi-asserted-by":"crossref","first-page":"e5234","DOI":"10.1371\/journal.pone.0005234","article-title":"Chronic granulomatous disease: the European experience","volume":"4","author":"van den Berg","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2011.05.024_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clim.2009.05.001","article-title":"Granulomatous disease in common variable immunodeficiency","volume":"133","author":"Ardeniz","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2011.05.024_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2010-01-254417","article-title":"How I treat common variable immune deficiency","volume":"116","author":"Cunningham-Rundles","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.05.024_bib18","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJMoa073966","article-title":"An immunodeficiency disease with RAG mutations and granulomas","volume":"358","author":"Schuetz","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.05.024_bib19","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.coi.2009.06.003","article-title":"The immunopathogenesis of Crohn\u2019s disease: a three-stage model","volume":"21","author":"Sewell","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2011.05.024_bib20","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1172\/JCI25178","article-title":"A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection","volume":"115","author":"de Villartay","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2011.05.024_bib21","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1182\/blood.V88.5.1708.1708","article-title":"T-lymphocyte differentiation and proliferation in the absence of the cytoplasmic tail of the common cytokine receptor gamma c chain in a severe combined immune deficiency X1 patient","volume":"88","author":"Morelon","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.05.024_bib22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-3476(97)70200-2","article-title":"Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations","volume":"130","author":"Comans-Bitter","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2011.05.024_bib24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0190-9622(95)90016-0","article-title":"Genetic immunodeficiencies: cutaneous manifestations and recent progress","volume":"33","author":"Arbiser","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2011.05.024_bib25","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2169\/internalmedicine.46.6414","article-title":"Fever of unknown origin in a patient with common variable immunodeficiency associated with multisystemic granulomatous disease","volume":"46","author":"Fernandez-Ruiz","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.jaci.2011.05.024_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s11882-005-0008-x","article-title":"Granulomatous disease in common variable immunodeficiency","volume":"5","author":"Morimoto","year":"2005","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2011.05.024_bib27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1525-1470.1995.tb00147.x","article-title":"Caseating cutaneous granulomas in a child with common variable immunodeficiency","volume":"12","author":"Torrelo","year":"1995","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaci.2011.05.024_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000246117","article-title":"Cutaneous granulomas as a presenting sign in ataxia-telangiectasia","volume":"194","author":"Drolet","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2011.05.024_bib29","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0022-3476(05)83043-4","article-title":"Cutaneous granulomatous lesions in patients with ataxia-telangiectasia","volume":"119","author":"Paller","year":"1991","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2011.05.024_bib30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0190-9622(91)70097-L","article-title":"Caseating cutaneous granulomas in a patient with X-linked infantile hypogammaglobulinemia","volume":"24","author":"Fleming","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2011.05.024_bib31","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1182\/blood-2010-02-267583","article-title":"Hypomorphic Rag mutations can cause destructive midline granulomatous disease","volume":"116","author":"De Ravin","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.05.024_bib32","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s10875-009-9349-x","article-title":"Chronic inflammatory bowel disease as key manifestation of atypical ARTEMIS deficiency","volume":"30","author":"Rohr","year":"2010","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2011.05.024_bib33","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1525-1470.2010.01140.x","article-title":"Chronic noninfectious necrotizing granulomas in a child with Nijmegen breakage syndrome","volume":"27","author":"Vogel","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaci.2011.05.024_bib34","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1128\/CMR.17.4.840-862.2004","article-title":"Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases","volume":"17","author":"Clarridge","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jaci.2011.05.024_bib35","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJMp0708085","article-title":"The new age of molecular diagnostics for microbial agents","volume":"358","author":"Whitley","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2011.05.024_bib36","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1600-0560.2007.00854.x","article-title":"Immunohistochemical features of cutaneous granulomas in primary immunodeficiency disorders: a comparison with cutaneous sarcoidosis","volume":"35","author":"de Jager","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaci.2011.05.024_bib37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0952-7915(92)90084-R","article-title":"Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta)","volume":"4","author":"Ruddle","year":"1992","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2011.05.024_bib38","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cytogfr.2008.04.010","article-title":"Physiological functions of tumor necrosis factor and the consequences of its pathologic overexpression or blockade: mouse models","volume":"19","author":"Kruglov","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jaci.2011.05.024_bib39","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0092-8674(89)90676-4","article-title":"The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection","volume":"56","author":"Kindler","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2011.05.024_bib40","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V87.2.674.bloodjournal872674","article-title":"Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency\u2014possible immunologic and clinical consequences","volume":"87","author":"Aukrust","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2011.05.024_bib41","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.4049\/jimmunol.159.12.6236","article-title":"TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease","volume":"159","author":"Mullighan","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2011.05.024_bib42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2133.2005.06619.x","article-title":"Cutaneous granulomas associated with primary immunodeficiency disorders","volume":"153","author":"Mitra","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2011.05.024_bib43","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cgh.2008.03.014","article-title":"Efficacy and safety of tumor necrosis factor antagonists in Crohn\u2019s disease: meta-analysis of placebo-controlled trials","volume":"6","author":"Peyrin-Biroulet","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"suppl","key":"10.1016\/j.jaci.2011.05.024_bib44","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/NAN.0b013e318192e311","article-title":"Biologic agents for rheumatoid arthritis: 2008 and beyond","volume":"32","author":"Sweiss","year":"2009","journal-title":"J Infus Nurs"},{"key":"10.1016\/j.jaci.2011.05.024_bib45","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1600-0463.2006.apm_522.x","article-title":"Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation","volume":"114","author":"Milman","year":"2006","journal-title":"APMIS"},{"key":"10.1016\/j.jaci.2011.05.024_bib46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1081-1206(10)61228-8","article-title":"Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature","volume":"95","author":"Thatayatikom","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2011.05.024_bib47","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jaci.2005.08.041","article-title":"Caseating granulomatous disease in common variable immunodeficiency treated with infliximab","volume":"116","author":"Hatab","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.05.024_bib48","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jaci.2006.01.034","article-title":"Etanercept treatment of cutaneous granulomas in common variable immunodeficiency","volume":"117","author":"Lin","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.05.024_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2007.08.010","article-title":"Treatments for pulmonary sarcoidosis","volume":"102","author":"Paramothayan","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.jaci.2011.05.024_bib50","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jaci.2010.08.009","article-title":"Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments","volume":"126","author":"Marodi","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2011.05.024_bib51","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ibd.20131","article-title":"Infliximab and the risk of latent viruses reactivation in active Crohn\u2019s disease","volume":"13","author":"Lavagna","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jaci.2011.05.024_bib52","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000221005","article-title":"Refractory chronic cutaneous sarcoidosis responsive to dose escalation of TNF-alpha antagonists","volume":"219","author":"Thielen","year":"2009","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2011.05.024_bib53","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1002\/art.27687","article-title":"A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab","volume":"62","author":"Kumar","year":"2010","journal-title":"Arthritis Rheum"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911008487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674911008487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:28:59Z","timestamp":1758788939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674911008487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0091674911008487"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2011.05.024","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Granulomatous inflammation in cartilage-hair hypoplasia: Risks and benefits of anti\u2013TNF-\u03b1 mAbs","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2011.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}